[Outcome of haploidentical hematopoietic stem cell transplantation for aggressive natural killer cell leukemia].
作者信息
Xia J, Chen S N, Jin Z M, Tang X W, Chen F, Ma X, Miao M, Wu D P
机构信息
National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2021 Jul 14;42(7):591-593. doi: 10.3760/cma.j.issn.0253-2727.2021.07.010.
Abstract
摘要
相似文献
1
[Outcome of haploidentical hematopoietic stem cell transplantation for aggressive natural killer cell leukemia].
Zhonghua Xue Ye Xue Za Zhi. 2021 Jul 14;42(7):591-593. doi: 10.3760/cma.j.issn.0253-2727.2021.07.010.
2
The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease.
Haematologica. 2008 Dec;93(12):1852-8. doi: 10.3324/haematol.13033. Epub 2008 Oct 22.
3
Donor-derived natural killer cells infused after human leukocyte antigen-haploidentical hematopoietic cell transplantation: a dose-escalation study.
Biol Blood Marrow Transplant. 2014 May;20(5):696-704. doi: 10.1016/j.bbmt.2014.01.031. Epub 2014 Feb 11.
4
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study.
Haematologica. 2012 Oct;97(10):1523-31. doi: 10.3324/haematol.2011.059378. Epub 2012 Apr 4.
5
[Clinical research of HLA-haploidentical peripheral hematopoietic stem cell transplantation following reduced intensity conditioning regimen with hematological malignancy patients over 50 years old].
Zhonghua Xue Ye Xue Za Zhi. 2019 Aug 14;40(8):667-672. doi: 10.3760/cma.j.issn.0253-2727.2019.08.008.
6
Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
Biol Blood Marrow Transplant. 2016 Jul;22(7):1290-1298. doi: 10.1016/j.bbmt.2016.04.009. Epub 2016 Apr 16.
7
Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica. 2017 Nov;102(11):1810-1822. doi: 10.3324/haematol.2017.176107. Epub 2017 Sep 7.
8
Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.
Haematologica. 2014 Dec;99(12):1860-7. doi: 10.3324/haematol.2014.108407. Epub 2014 Aug 1.
9
Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant. 2016 Apr;22(4):705-709. doi: 10.1016/j.bbmt.2015.12.028. Epub 2016 Jan 6.
10
Comparison of 2 Different Doses of Antithymocyte Globulin in Conditioning Regimens for Haploidentical Hematopoietic Stem Cell Transplantation.
Exp Clin Transplant. 2022 Jan;20(1):69-76. doi: 10.6002/ect.2021.0003. Epub 2021 Aug 9.
本文引用的文献
1
Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A second experience.
Am J Hematol. 2018 May;93(5):E123-E125. doi: 10.1002/ajh.25063. Epub 2018 Feb 24.
2
Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis.
Blood Adv. 2017 Aug 17;1(19):1533-1536. doi: 10.1182/bloodadvances.2017007526. eCollection 2017 Aug 22.
3
Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes.
Blood Cancer J. 2017 Dec 21;7(12):660. doi: 10.1038/s41408-017-0021-z.
4
Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice.
Blood. 2016 Jul 7;128(1):60-71. doi: 10.1182/blood-2016-02-700013. Epub 2016 May 24.
5
L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia.
J Hematol Oncol. 2016 Apr 18;9:41. doi: 10.1186/s13045-016-0271-4.
6
Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis.
Blood. 2016 Mar 31;127(13):1666-75. doi: 10.1182/blood-2015-12-684399. Epub 2016 Jan 29.
7
Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation.
Cancer Sci. 2012 Jun;103(6):1079-83. doi: 10.1111/j.1349-7006.2012.02251.x. Epub 2012 Mar 23.
8
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.
J Clin Oncol. 2011 Nov 20;29(33):4410-6. doi: 10.1200/JCO.2011.35.6287. Epub 2011 Oct 11.
9
The diagnosis and management of extranodal NK/T-cell lymphoma, nasal-type and aggressive NK-cell leukemia.
J Clin Exp Hematop. 2011;51(1):21-8. doi: 10.3960/jslrt.51.21.
10
Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.
Int J Hematol. 2010 Dec;92(5):697-701. doi: 10.1007/s12185-010-0726-2. Epub 2010 Dec 1.
Zotero 插件